Innosuisse, the Swiss Agency for Innovation Promotion, is supporting another research project on COVID-19 from the University Hospital of Basel:

The project "Wirksamkeit antimikrobieller Oberflächen im Spital zur Reduktion der Umwelt-Keimbelastung und Transmission multiresistenter Erreger" is headed by DKF research group leader Prof. Andreas F. Widmer (Infectiology & Hospital Hygiene/USB)